The World Health Organization Says Insecticide Lindane, DDT may Cause Cancer

The World Health Organization (WHO) has revealed that lindane, an insecticide, widely used in agriculture and to treat human lice and scabies, can cause cancer and has been specifically linked to the occurrence of non-Hodgkin lymphoma, a rare kind of cancer.

Lindane is banned in U.K and the U.S. Even today lindane is used as an ingredient in treatment for lice and scabies in Canada, India and China. According to WHO, people in Britain might still be exposed to chemical via food products imported from developing countries.

50 Everyday Used Chemicals Found to Trigger the Development of Cancer
With humans being routinely exposed to thousands of chemicals everyday, the effects need to be better understood to reduce the incidence of cancer globally.

WHO’s International Agency for Research in Cancer (IARC) further revealed that dichlorodiphenyltrichloroethane (DDT) could be carcinogenic. Researchers found evidence that linked exposure of DDT to increased risk of non-Hodgkin lymphoma (NHL), testicular cancer and liver cancer.

Dr. Kurt Straif of IARC, said "The agricultural usage of Lindane has been severely restricted starting in the 1970s and current general-population exposure is mainly through diet or when treated for scabies or lice. There are currently no epidemiological studies to quantify the lymphoma risk from these exposures."

In a review of various agricultural chemicals, IARC’s specialist panel classified lindane as "carcinogenic to humans" in its Group 1 category, DDT as "probably carcinogenic to humans" in its Group 2A class, and the herbicide 2,4-D as "possibly carcinogenic to humans" in its Group 2B.

Zinc Oxide can Cause Cancer: Study
Zinc oxide, chemical present in consumer products may cause cancer, suggests study.

IARC said exposure to chemicals occur during manufacturing and application, people in the general population can be exposed through food, water, dust, residential application and during spraying.

Source-Medindia

Researchers Unveil Surface Sampling Probe for Surgeons Treating Cancer Patients
Automated droplet-based surface sampling probe analyzes cancerous tissue sample within 10 minutes, which usually takes 20 to 30 minutes in traditional methods.

New Test That Uses Blood and Saliva to Detect Head and Neck Cancers
The blood and saliva tests have raised hope for a cheap screening test that dentists or doctors could one day deliver during regular office visits.